AFFF – FIRE FIREFIGHTER FOAM
The firefighting foam, widely recognized as Aqueous Film-Forming Foam (AFFF), has become a subject of increasing legal disputes. Employed extensively since the 1960s, this foam is primarily utilized by the military and at airports for its effectiveness in extinguishing fires fueled by jet fuel and petroleum. The fundamental component of this foam, per- and poly-fluoroalkyl substances (PFAS), is currently undergoing thorough scrutiny due to concerns about its potential carcinogenic properties.
Learn If Your Case Is Eligible
Diving into a legal battle against a giant corporation may seem impossible, especially if you are dealing with illness. TortSource is here to make this journey as stress-free as possible for you, starting with a no-cost case review to answer all your questions and determine if you may qualify for a settlement.
🔒 All information is secure and will never be released
By providing your cell number you acknowledge and consent to receive and exchange communications via text messaging (SMS) and receive automated text messages and/or to receive and exchange communications via an automated telephone dialing system. Messaging and data rates may apply. Text “stop” to opt out at any time. No purchase necessary.
How It Works
Fill out the form or call us toll-free at 855-942-3317. We’ll be in touch within hours to hear your story, answer your questions, and determine if you may qualify for a settlement.
Allow us to gather key medical records and match you with a trusted legal expert who has won cases like yours.
We handle every aspect of building and fighting your case, so you can focus on living peacefully. You pay nothing if you aren’t awarded a settlement.
There are time deadlines to file a claim.
To discuss your claim immediately, click the “Call Us” button, or dial 855-942-3317
Designated by the U.S. Environmental Protection Agency (EPA) as potentially harmful to human health, PFAS exposure is accused of being the contributing factor to various forms of cancer among firefighters. These encompass bladder, breast, colorectal, leukemia, liver, lymphoma, pancreatic, prostate, renal or kidney, testicular, thyroid cancer and disease, ulcerative colitis, and uterine or endometrial cancer. A total of over 4,000 lawsuits have been initiated by claimants who assert the development of these cancer types due to consistent exposure to AFFF. These lawsuits are presently in the process of consolidation in the United States Federal Court in the District of South Carolina, under the oversight of a single judge for pretrial proceedings. The objective is to streamline the legal proceedings and potentially lay the groundwork for a comprehensive settlement.
